PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carol G. Gallagher Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Turning Point Therapeutics Inc (Director · Jul 24, 2019 – Aug 17, 2022 · Past); Tempest Therapeutics, Inc. (Director · Jun 20, 2019 – Jun 22, 2020 · Past) | Director · Since at least Nov 3, 2022 |
| Richard Heyman Other companies: Enliven Therapeutics, Inc. (Director · Since at least Feb 23, 2023); ORIC Pharmaceuticals, Inc. (Chairman · Since at least Apr 23, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Kineta Inc. (Director · Dec 22, 2020 – Jun 2, 2021 · Past); Metacrine Inc (Director · Sep 15, 2020 – May 18, 2022 · Past); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Jun 17, 2022 · Past) | Director · Since at least Sep 24, 2020 |
| Arnold L Oronsky Other companies: KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 1, 2020 · Past); MacroGenics, Inc. (Director · Oct 9, 2013 – Feb 18, 2014 · Past); Tesaro Inc (Director · Jun 27, 2012 – Aug 7, 2018 · Past); Anesiva Inc (Director · Jun 22, 2006 – May 9, 2008 · Past); Myogen Inc (Director · May 4, 2006 – Nov 13, 2006 · Past); Dynavax Technologies Corporation (Director · Feb 23, 2006 – May 28, 2020 · Past) | Director · Sep 24, 2020 – Sep 25, 2020 · Past |
| Charles Baum Other companies: Acrivon Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Poseida Therapeutics Inc (Director · May 16, 2022 – Jan 8, 2025 · Past); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Immunomedics Inc (Director · Feb 23, 2019 – Oct 23, 2020 · Past) | Director · Since at least Apr 1, 2021 |
| Laurie Stelzer Other companies: MBX Biosciences, Inc. (Director · Since at least Jan 20, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Spyre Therapeutics, Inc. (Chair of the Audit Committee · Since at least Nov 22, 2023); Surface Oncology Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past) | Chair, Board of Directors · Since at least Jun 2, 2022 |
| Thilo Schroeder Other companies: ARS Pharmaceuticals, Inc. (Director · Dec 3, 2020 – Dec 8, 2020 · Past); Revolution Medicines, Inc. (Director · Feb 12, 2020 – Dec 5, 2024 · Past); IDEAYA Biosciences, Inc. (Director · May 22, 2019 – May 22, 2019 · Past) | Director · Sep 24, 2020 – Oct 6, 2021 · Past |
| Winston Kung Other companies: Corbus Pharmaceuticals Holdings, Inc. (Director · Since at least Aug 16, 2024); ArriVent BioPharma, Inc. (Chief Financial Officer · Since at least Jan 25, 2024); Janux Therapeutics, Inc. (Director · Since at least Sep 21, 2022) | COO, CFO · Sep 24, 2020 – May 12, 2023 · Past |
| David H. Mack Other companies: Aduro Biotech Inc (Director · Feb 19, 2019 – May 5, 2020 · Past); Aerie Pharmaceuticals Inc. (Director · Oct 25, 2013 – Oct 25, 2013 · Past) | Co-Founder, President & CEO · Since at least Sep 24, 2020 |
| Arnold J Levine Other companies: MeiraGTx Holdings plc (Director · Jun 19, 2019 – Jun 7, 2022 · Past) | Director · Since at least Sep 24, 2020 |
| Kirsten Flowers Other companies: Kura Oncology, Inc. (CCO & Chief Strategy Officer · Jan 6, 2020 – Jan 27, 2023 · Past) | Director · Since at least Jan 5, 2022 |
| Robert Ticktin Other companies: EPIRUS Biopharmaceuticals Inc (General Counsel · Jul 15, 2014 – May 27, 2016 · Past) | General Counsel & COO · Since at least Apr 21, 2025 |
| Matt Eckler | Director · Since Oct 5, 2026 · Appointed, no departure found |
| Matt Eckler | Director · Since at least Oct 5, 2026 |
| Michael Carulli | Chief Financial Officer · Since at least Jan 5, 2024 |
| Philip Herman | Chief Commercial Officer · Since Sep 8, 2026 · Appointed, no departure found |
| Philip Herman | Chief Commercial Officer · Since at least Sep 8, 2026 |